Consolidated income statement

INCOME STATEMENT | Note | 2023 | 2022 (restated)** |
---|---|---|---|
Net interest income | 17 | 18,318 | 11,424 |
Interest and similar income | 31,217 | 19,751 | |
of which calculated under the effective interest rate method | 30,668 | 19,196 | |
Interest expense | (12,899) | (8,327) | |
Net fee and commission income | 18 | 4,626 | 4,498 |
Fee and commission income | 6,301 | 6,059 | |
Fee and commission expense | (1,675) | (1,561) | |
Other net income | 1,188 | 1,287 | |
Net income from insurance business, of which: | 39 | 711 | 779 |
Insurance revenue (net of reinsurance) | 1,242 | 1,174 | |
Cost of insurance activities (net of reinsurance) | (389) | (324) | |
Dividend income | 19 | 14 | 51 |
Gains/(losses) on financial transactions | 20 | 167 | 358 |
Foreign exchange gains/ (losses) | 21 | 99 | (73) |
Gains/(losses) on derecognition of financial instruments | 22 | 57 | (26) |
of which measured at amortized cost | 24 | 15 | |
Net other operating income and expense | 23 | 140 | 198 |
Result on business activities | 24,132 | 17,209 | |
Net allowances for expected credit losses | 24 | (1,265) | (1,501) |
Net impairment losses on non-financial assets | 25 | (108) | (63) |
Cost of legal risk of mortgage loans in convertible currencies | 26 | (5,430) | (1,914) |
Administrative expenses | 27 | (7,635) | (7,769) |
of which net regulatory charges | (622) | (1,887) | |
Tax on certain financial institutions | 28 | (1,231) | (1,266) |
Share in profits and losses of associates and joint ventures | 42 | 99 | 71 |
Profit before tax | 8,562 | 4,767 | |
Income tax expense | 29 | (3,057) | (1,455) |
Net profit/(loss) (including non-controlling interest) | 5,505 | 3,312 | |
Profit (loss) attributable to non-controlling shareholders | 3 | – | |
Net profit attributable to equity holders of the parent company | 5,502 | 3,312 | |
Earnings per share | 30 | ||
– basic earnings per share for the period (PLN) | 4.40 | 2.65 | |
– diluted earnings per share for the period (PLN)* | 4.40 | 2.65 | |
Weighted average number of ordinary shares during the period (in million)* | 1,250 | 1,250 |
* In 2023 and 2022, there were no dilutive instruments. Therefore, the amount of diluted earnings per share is the same as the amount of basic earnings per share.
** The Income statement for 2022 was restated due to the implementation of IFRS 17 “Insurance Contracts” (see note “ IFRS 17 Insurance Contracts”).
** The Income statement for 2022 was restated due to the implementation of IFRS 17 “Insurance Contracts” (see note “ IFRS 17 Insurance Contracts”).